Showing results (171-180 of 443) with videos related to

Sort By:
Pageof 45
Molecular Cancer Therapeutics|June 15, 2014
In vitro and in vivo activity of the low-immunogenic antimesothelin immunotoxin RG7787 in pancreatic cancerKevin Hollevoet, Emily Mason-Osann, Xiu-fen Liu, et al.
Plos One|October 12, 2012
Efficiency of immunotoxin cytotoxicity is modulated by the intracellular itineraryLori L Tortorella, Nina H Pipalia, Sushmita Mukherjee, et al.
Cancer Research|February 20, 2007
NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cellsSudipto Das, Yoonsoo Hahn, Satoshi Nagata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reactionEvgeny Arons, Inger Margulies, Lynn Sorbara, et al.
The Journal of Biological Chemistry|March 15, 2013
A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 geneHui Wei, Tapan K Bera, Alan S Wayne, et al.
Leukemia Research|September 28, 2013
Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8Xiaobo Hu, Hui Wei, Laiman Xiang, et al.
JCO Precision Oncology|October 30, 2018
Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant MesotheliomaLiang Cao, Yunkai Yu, Anish Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosisXiu Fen Liu, Laiman Xiang, Qi Zhou, et al.
American Journal of Physiology. Renal Physiology|March 15, 2021
Indirect podocyte injury manifested in a partial podocytectomy mouse modelMasahiro Okabe, Kazuyoshi Yamamoto, Yoichi Miyazaki, et al.
Pageof 45